Research and Markets: Women's Health - Infertility Drug Pipeline Report
Posted on: Wednesday, 11 July 2007, 09:04 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62349) has announced the addition of Women's Health - Infertility Drug Pipeline Report to their offering.
"Women's Health - Infertility Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of infertility drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Content Outline:
UPCOMING PATENT EXPIRES BY THERAPY AREA
Infertility Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Infertility Projects
--Top 20 companies in early stage Infertility Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c62349
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Innovation Leader Endorses IFT-NPD for Managing Innovation and New Product Development With Stage-Gate(R) Ready Certification Version II Criteria
- Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
- Revolutions Medical Signs Contract for Rev Vac Manufacturing Service With Strategic Product Development, Inc.
- Energy, Refining and Pipeline Construction Projects Push Wisconsin Industrial Development to $14.6 Billion, an Industrial Info News Alert
- Heartland Oil and Gas Continues Production Enhancement and Well and Pipeline Expansion Projects in Texas and Kansas
- RuleStream and EAC Product Development Solutions Announce Strategic Partnership
- Energy Transfer Partners, L.P. Announces Completion of First Phase of 42-Inch Pipeline Expansion Project
- ARIAD Reports Fourth Quarter and Year-End 2005 Results; Product Development Goals and Financial Guidance for 2006 Provided
- Cordiant Technologies Announces Outsourced Product Development Services for Small and Mid-Sized ISVs; India-Based Solutions Provider Offers Cost Effective, Flexible Options for Software Vendors
- Point Therapeutics Awarded $600,000 Orphan Products Development Grant to Fund Company's Current Phase 2 Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia
 |
 |
User Comments (0)
RSS Feeds